Episode
Building Cell Therapy Companies With Kenai Therapeutics' Nick Manusos
- Podcast
- Business Of Biotech
- Published
- Dec 29, 2025
- Duration seconds
- 2799
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/business-of-biotech-123501/episodes/building-cell-therapy-companies-with-kenai-therapeutics-nick-manusos/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/business-of-biotech-123501/building-cell-therapy-companies-with-kenai-therapeutics-nick-manusos.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Nick Manusos, CEO at Kenai Therapeutics, talks about his experiences building cell therapy spinouts from FujiFilm Cellular Dynamics, learning from big pharma decision-making processes, and dosing the first patient with Kenai's allogeneic neuron replacement cell therapy for Parkinson's disease. Nick also talks about funding an early-stage cell therapy company and forging key manufacturing...